We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

By HospiMedica International staff writers
Posted on 17 Feb 2026

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. More...

This fragmented view forces clinicians to infer electrical activity they cannot directly observe, potentially missing circuits deep within the heart wall or spanning multiple chambers. Such limitations can prolong procedures and increase complexity during ablation therapy. Researchers have now developed a system capable of simultaneously mapping all four chambers of the heart, delivering a comprehensive, real-time 3D view of arrhythmias.

In a collaborative breakthrough, researchers from the Universitat Politècnica de València (UPV, Valencia, Spain) and the Corify Care (Madrid, Spain) have developed the new platform that visualizes the interior of the heart, including walls and septum, generating a complete map of cardiac electrical activity within a single heartbeat. The patented Global Volumetric Mapping technology evolved from earlier systems that mapped only the heart’s surface. This volumetric approach allows clinicians to observe how arrhythmia propagates through the heart wall and between chambers before and during ablation procedures.

The ACORYS system was evaluated in a multicenter study involving several European clinical and research institutions. The results demonstrated that technology could identify arrhythmia pathways often undetected by conventional tools, including circuits located deep within myocardial tissue. The findings, published in Nature Communications Medicine, validate the first system capable of comprehensive four-chamber mapping in real time, overcoming previous mathematical and technical limitations in arrhythmia characterization.

By eliminating blind spots, the platform may enable faster decision-making, more targeted ablations, and reduced procedural time. Researchers suggest that holistic visualization of arrhythmias could improve workflow efficiency and clinical outcomes in electrophysiology laboratories. The ACORYS system is CE marked and currently under FDA review in the United States. Corify Care is advancing integration with catheter navigation platforms and expanding research into volumetric cardiac analysis to support broader clinical adoption.

“It’s about visibility and confidence. We give doctors the whole picture from the start, not fragments,” said Andreu Climent, PhD, CEO of Corify Care and researcher at Universitat Politècnica de València. A global view means faster decisions, more targeted ablations, and the potential to reduce the time and complexity of the procedure.”

Related Links:
UPV
Corify Care


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.